{"title": "140 estudios cient\u00edficos sobre eventos adversos de la inyecci\u00f3n K0 B1T que pueden ocurrir en los ni\u00f1os", "author": "Bree", "url": "https://cienciaysaludnatural.com/140-estudios-cientificos-sobre-eventos-adversos-de-la-inyeccion-k0-b1t-que-pueden-ocurrir-en-los-ninos/", "hostname": "cienciaysaludnatural.com", "description": "El estudio de adolescentes de Pfizer no fue dise\u00f1ado para encontrar eventos adversos graves, ni muertes.", "sitename": "CienciaySaludNatural.com", "date": "2021-12-30", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Los propios datos del informe de 6 meses de Pfizer sobre su inoculaci\u00f3n de COVID-19 muestran que la enfermedad y la muerte son mayores en los inoculados que en el grupo placebo. Adem\u00e1s, dise\u00f1o de prueba deficiente, datos faltantes, vigilancia pasiva y otras negligencias alarmantes.\n[Colabore con nosotro](https://cienciaysaludnatural.com/colaboracion/)s para que podamos seguir subtitulando videos y publicando esta web , gracias.\nEl\n[estudio de adolescentes de Pfizer](https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf) en realidad [no fue dise\u00f1ado](https://www.canadiancovidcarealliance.org/wp-content/uploads/2021/12/The-COVID-19-Inoculations-More-Harm-Than-Good-REV-Dec-16-2021.pdf) para encontrar eventos adversos graves, incluida la muerte. [Canadian COVID Care Alliance](https://www.canadiancovidcarealliance.org/) (CCCA) es un grupo de \u201cm\u00e9dicos, cient\u00edficos y profesionales de la salud canadienses independientes comprometidos con brindar informaci\u00f3n de la mejor calidad y basada en evidencia al p\u00fablico canadiense sobre COVID-19 para que se puedan reducir las hospitalizaciones, salvar vidas y restaurando la salud de la manera m\u00e1s segura posible \u00ab.\nCCCA prepar\u00f3 una presentaci\u00f3n que demuestra de manera exhaustiva c\u00f3mo el supuesto estudio aleatorizado, controlado con placebo y doble ciego de Pfizer se desvi\u00f3 de las metodolog\u00edas que habr\u00edan respondido definitivamente a las preguntas de seguridad y eficacia.\nEn esta presentaci\u00f3n de\n[diapositivas](https://www.canadiancovidcarealliance.org/wp-content/uploads/2021/12/The-COVID-19-Inoculations-More-Harm-Than-Good-REV-Dec-16-2021.pdf) concisa con un [video](https://www.canadiancovidcarealliance.org/) explicativo , CCCA resumi\u00f3 de manera contundente por qu\u00e9 la prueba de Pfizer no fue dise\u00f1ada para demostrar adecuadamente la seguridad y eficacia de su producto.\nAqu\u00ed hay algunos puntos clave de la presentaci\u00f3n de CCCA:\n- Los datos iniciales demostraron una alta reducci\u00f3n del riesgo relativo de infecci\u00f3n, pero esto represent\u00f3 una reducci\u00f3n absoluta del riesgo de solo 0,84%. Es la reducci\u00f3n absoluta del riesgo lo que determina la relaci\u00f3n riesgo-beneficio necesaria para tomar decisiones informadas sobre la inoculaci\u00f3n.\n- Desenmascaramiento temprano: varios meses antes de publicar los resultados de la observaci\u00f3n de seis meses, Pfizer opt\u00f3 por ofrecer su producto a los participantes que recibieron el placebo. Al eliminar a casi todos los participantes en el grupo placebo, Pfizer cerr\u00f3 efectivamente su experimento porque ya no se pueden hacer comparaciones a largo plazo.\n- No se consideraron la mortalidad y morbilidad por todas las causas, los \u00fanicos resultados razonables que se pueden utilizar para determinar la eficacia y el riesgo. De hecho, la mortalidad por todas las causas fue mayor en el grupo vacunado despu\u00e9s de seis meses.\n- Los eventos adversos graves superaron en n\u00famero a los casos de COVID grave conocidos despu\u00e9s de seis meses de observaci\u00f3n.\n- Los participantes del ensayo no reflejaban a los miembros m\u00e1s vulnerables de nuestra poblaci\u00f3n:\n[m\u00e1s del 50% de las personas que mueren de COVID tienen 75 a\u00f1os de edad o m\u00e1s](https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm). Este grupo de edad represent\u00f3 solo el 4,4% de los participantes del ensayo. Adem\u00e1s, el 95% de los que han muerto por COVID ten\u00edan una o m\u00e1s comorbilidades. Casi el 80% de los participantes del ensayo no ten\u00edan ninguna.\n- No a todos los participantes del ensayo se les hizo la prueba de COVID. Se pasaron por alto casos asintom\u00e1ticos o paucisintom\u00e1ticos (que presentaban pocos s\u00edntomas).\nPreguntas sobre la falta de cegamiento y la integridad de los datos\nLa presentaci\u00f3n de la CCCA tambi\u00e9n resucita una observaci\u00f3n desconcertante mencionada en un\n[documento informativo que](https://www.fda.gov/media/144416/download) Pfizer present\u00f3 solo al Comit\u00e9 Asesor de Vacunas y Productos Biol\u00f3gicos Relacionados de la FDA (VRBPAC) de la FDA, pero en ning\u00fan otro lugar, incluido el resumen del ensayo ampliamente citado publicado en New England Journal. de Medicina.\nSeg\u00fan el documento, por su presentaci\u00f3n cl\u00ednica se sospechaba que 3.410 participantes ten\u00edan COVID, pero fueron excluidos de los c\u00e1lculos de eficacia porque no se pudo confirmar un diagn\u00f3stico mediante la prueba de PCR .\nLa presentaci\u00f3n de la CCCA supone que este gran grupo de participantes nunca fue evaluado. La redacci\u00f3n en el documento informativo VRBPAC es de hecho vaga, indicando que los participantes \u201cno fueron confirmados por PCR\u201d en una oraci\u00f3n y \u201cno confirmados\u201d en otra.\nSuponiendo que los investigadores de Pfizer siguieron su protocolo de estudio, estos participantes fueron de hecho evaluados. Sin embargo, eso nos obliga a aceptar que m\u00e1s de 3.400 participantes que ten\u00edan s\u00edntomas de COVID padec\u00edan otras enfermedades, no COVID.\nEn otras palabras, hubo 3.580 participantes que se presentaron cl\u00ednicamente con COVID (3410 sospechosos y 170 confirmados). De estos, m\u00e1s del 95% dieron negativo. Esto es dif\u00edcil de aceptar en un grupo donde la sospecha cl\u00ednica es alta.\nSin embargo, sin m\u00e1s pruebas por parte de los investigadores, nos queda aceptar estos n\u00fameros tal como se informaron.\nPeter Doshi, Ph.D., editor senior de The BMJ, explic\u00f3 las implicaciones de este resultado en detalle, en un art\u00edculo de\n[opini\u00f3n](https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data/) publicado hace casi un a\u00f1o.\nEn su comentario ampliamente discutido, Doshi se\u00f1al\u00f3 otro hallazgo desconcertante en los datos de Pfizer. Dentro de los 7 d\u00edas de la administraci\u00f3n de la segunda de dos dosis, 371 (310 en el grupo vacunado y 61 en el grupo placebo) se retiraron del estudio debido a \u00abdesviaciones importantes del protocolo\u00bb.\nPor supuesto, se producen desviaciones del protocolo, pero \u00bfpor qu\u00e9 se excluyeron cinco veces m\u00e1s receptores de vacunas que receptores de placebo en ese punto del estudio?\nAunque hab\u00eda cerca de 40.000 participantes en la poblaci\u00f3n evaluable, solo 170 contribuyeron al c\u00e1lculo de la eficacia con respecto a la protecci\u00f3n contra la infecci\u00f3n y solo 10 con respecto a la protecci\u00f3n contra la infecci\u00f3n grave.\nEn otras palabras, solo un pu\u00f1ado de participantes diagnosticados y categorizados incorrectamente podr\u00eda f\u00e1cilmente dar como resultado una estimaci\u00f3n sustancialmente diferente de la eficacia y seguridad de la vacuna.\n140 referencias sobre eventos adversos de la inyecci\u00f3n K0 B1T que pueden ocurrir en los ni\u00f1os\nAbbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., . . . Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int J Cardiol, 340, 119-121. doi:10.1016/j.ijcard.2021.08.018.\n[https://www.ncbi.nlm.nih.gov/pubmed/34416319](https://www.ncbi.nlm.nih.gov/pubmed/34416319)\nAbu Mouch, S., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L., . . . Berar Yanay, N. (2021). Myocarditis following COVID-19 mRNA vaccination. Vaccine, 39(29), 3790-3793. doi:10.1016/j.vaccine.2021.05.087.\n[https://www.ncbi.nlm.nih.gov/pubmed/34092429](https://www.ncbi.nlm.nih.gov/pubmed/34092429)\nAlbert, E., Aurigemma, G., Saucedo, J., & Gerson, D. S. (2021). Myocarditis following COVID-19 vaccination. Radiol Case Rep, 16(8), 2142-2145. doi:10.1016/j.radcr.2021.05.033.\n[https://www.ncbi.nlm.nih.gov/pubmed/34025885](https://www.ncbi.nlm.nih.gov/pubmed/34025885)\nAye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., . . . Chew, N. W. S. (2021). Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination. QJM. doi:10.1093/qjmed/hcab252.\n[https://www.ncbi.nlm.nih.gov/pubmed/34586408](https://www.ncbi.nlm.nih.gov/pubmed/34586408)\nAzir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. J Emerg Med, 61(6), e129-e132. doi:10.1016/j.jemermed.2021.09.017.\n[https://www.ncbi.nlm.nih.gov/pubmed/34756746](https://www.ncbi.nlm.nih.gov/pubmed/34756746)\nBarda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., . . . Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med, 385(12), 1078-1090. doi:10.1056/NEJMoa2110475.\n[https://www.ncbi.nlm.nih.gov/pubmed/34432976](https://www.ncbi.nlm.nih.gov/pubmed/34432976)\nBhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus and cardiovascular manifestations- getting to the heart of the matter. World J Cardiol, 13(10), 556-565. doi:10.4330/wjc.v13.i10.556.\n[https://www.ncbi.nlm.nih.gov/pubmed/34754400](https://www.ncbi.nlm.nih.gov/pubmed/34754400)\nBozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis With COVID-19 mRNA Vaccines. Circulation, 144(6), 471-484. doi:10.1161/CIRCULATIONAHA.121.056135.\n[https://www.ncbi.nlm.nih.gov/pubmed/34281357](https://www.ncbi.nlm.nih.gov/pubmed/34281357)\nBuchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome? Vaccines (Basel), 9(11). doi:10.3390/vaccines9111353.\n[https://www.ncbi.nlm.nih.gov/pubmed/34835284](https://www.ncbi.nlm.nih.gov/pubmed/34835284)\nCalcaterra, G., Bassareo, P. P., Barilla, F., Romeo, F., & Mehta, J. L. (2022). Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. J Cardiovasc Med (Hagerstown), 23(2), 71-74. doi:10.2459/JCM.0000000000001232.\n[https://www.ncbi.nlm.nih.gov/pubmed/34366403](https://www.ncbi.nlm.nih.gov/pubmed/34366403)\nCalcaterra, G., Mehta, J. L., de Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis. Pediatr Rep, 13(3), 530-533. doi:10.3390/pediatric13030061.\n[https://www.ncbi.nlm.nih.gov/pubmed/34564344](https://www.ncbi.nlm.nih.gov/pubmed/34564344)\nChai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Moller, A. M., & Thorvig, C. M. (2022). Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine. Acta Paediatr, 111(1), 125-127. doi:10.1111/apa.16141.\n[https://www.ncbi.nlm.nih.gov/pubmed/34617315](https://www.ncbi.nlm.nih.gov/pubmed/34617315)\nChamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., . . . Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis? Clin Res Cardiol, 110(11), 1850-1854. doi:10.1007/s00392-021-01916-w.\n[https://www.ncbi.nlm.nih.gov/pubmed/34333695](https://www.ncbi.nlm.nih.gov/pubmed/34333695)\nChang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina (Kaunas), 57(11). doi:10.3390/medicina57111163.\n[https://www.ncbi.nlm.nih.gov/pubmed/34833382](https://www.ncbi.nlm.nih.gov/pubmed/34833382)\nChelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents. AJR Am J Roentgenol. doi:10.2214/AJR.21.26853.\n[https://www.ncbi.nlm.nih.gov/pubmed/34704459](https://www.ncbi.nlm.nih.gov/pubmed/34704459)\nChoi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., . . . Yeo, N. S. (2021). Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings. J Korean Med Sci, 36(40), e286. doi:10.3346/jkms.2021.36.e286.\n[https://www.ncbi.nlm.nih.gov/pubmed/34664804](https://www.ncbi.nlm.nih.gov/pubmed/34664804)\nChouchana, L., Blet, A., Al-Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., . . . Liu, P. P. (2021). Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level. Clin Pharmacol Ther. doi:10.1002/cpt.2499.\n[https://www.ncbi.nlm.nih.gov/pubmed/34860360](https://www.ncbi.nlm.nih.gov/pubmed/34860360)\nChua, G. T., Kwan, M. Y. W., Chui, C. S. L., Smith, R. D., Cheung, E. C., Tian, T., . . . Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clin Infect Dis. doi:10.1093/cid/ciab989.\n[https://www.ncbi.nlm.nih.gov/pubmed/34849657](https://www.ncbi.nlm.nih.gov/pubmed/34849657)\nClarke, R., & Ioannou, A. (2021). Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? J Pediatr. doi:10.1016/j.jpeds.2021.12.026.\n[https://www.ncbi.nlm.nih.gov/pubmed/34933012](https://www.ncbi.nlm.nih.gov/pubmed/34933012)\nColaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., . . . Bruno, R. (2021). COVID vaccination and asthma exacerbation: might there be a link? Int J Infect Dis, 112, 243-246. doi:10.1016/j.ijid.2021.09.026.\n[https://www.ncbi.nlm.nih.gov/pubmed/34547487](https://www.ncbi.nlm.nih.gov/pubmed/34547487)\nDas, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., . . . Khan, D. (2021). Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr, 238, 26-32 e21. doi:10.1016/j.jpeds.2021.07.044.\n[https://www.ncbi.nlm.nih.gov/pubmed/34339728](https://www.ncbi.nlm.nih.gov/pubmed/34339728)\nDas, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far? Children (Basel), 8(7). doi:10.3390/children8070607.\n[https://www.ncbi.nlm.nih.gov/pubmed/34356586](https://www.ncbi.nlm.nih.gov/pubmed/34356586)\nDeb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database. J Prim Care Community Health, 12, 21501327211029230. doi:10.1177/21501327211029230.\n[https://www.ncbi.nlm.nih.gov/pubmed/34219532](https://www.ncbi.nlm.nih.gov/pubmed/34219532)\nDickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., . . . Aurigemma, G. P. (2021). A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging, 14(9), 1862-1863. doi:10.1016/j.jcmg.2021.06.003.\n[https://www.ncbi.nlm.nih.gov/pubmed/34246585](https://www.ncbi.nlm.nih.gov/pubmed/34246585)\nDimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis Rheumatol. doi:10.1002/art.41977.\n[https://www.ncbi.nlm.nih.gov/pubmed/34492161](https://www.ncbi.nlm.nih.gov/pubmed/34492161)\nDimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2021). Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Ann Rheum Dis. doi:10.1136/annrheumdis-2021-221607.\n[https://www.ncbi.nlm.nih.gov/pubmed/34844930](https://www.ncbi.nlm.nih.gov/pubmed/34844930)\nEhrlich, P., Klingel, K., Ohlmann-Knafo, S., Huttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clin Res Cardiol, 110(11), 1855-1859. doi:10.1007/s00392-021-01936-6.\n[https://www.ncbi.nlm.nih.gov/pubmed/34487236](https://www.ncbi.nlm.nih.gov/pubmed/34487236)\nEl Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., . . . Group, C. S. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med, 385(19), 1774-1785. doi:10.1056/NEJMoa2113017.\n[https://www.ncbi.nlm.nih.gov/pubmed/34551225](https://www.ncbi.nlm.nih.gov/pubmed/34551225)\nFacetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). [Acute myocarditis in a young adult two days after Pfizer vaccination]. G Ital Cardiol (Rome), 22(11), 891-893. doi:10.1714/3689.36746.\n[https://www.ncbi.nlm.nih.gov/pubmed/34709227](https://www.ncbi.nlm.nih.gov/pubmed/34709227)\nFazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J. M., Shekarriz-Foumani, R., . . . Safiri, S. (2021). Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev Med Virol, e2318. doi:10.1002/rmv.2318.\n[https://www.ncbi.nlm.nih.gov/pubmed/34921468](https://www.ncbi.nlm.nih.gov/pubmed/34921468)\nFazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., . . . Bonorino, C. (2021). Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nat Commun, 12(1), 6844. doi:10.1038/s41467-021-27120-y.\n[https://www.ncbi.nlm.nih.gov/pubmed/34824230](https://www.ncbi.nlm.nih.gov/pubmed/34824230)\nFikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U. (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1-9. Advance online publication.\n[https://doi.org/10.1007/s00392-020-01704-y](https://doi.org/10.1007/s00392-020-01704-y). Clin Res Cardiol, 110(8), 1352. doi:10.1007/s00392-021-01896-x. [https://www.ncbi.nlm.nih.gov/pubmed/34170372](https://www.ncbi.nlm.nih.gov/pubmed/34170372)\nFoltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., . . . Montastruc, F. (2021). Myocarditis and Pericarditis in Adolescents after First and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes. doi:10.1093/ehjqcco/qcab090.\n[https://www.ncbi.nlm.nih.gov/pubmed/34849667](https://www.ncbi.nlm.nih.gov/pubmed/34849667)\nForgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., & Ross, T. M. (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naive and Pre-Immune Humans. Front Immunol, 12, 728021. doi:10.3389/fimmu.2021.728021.\n[https://www.ncbi.nlm.nih.gov/pubmed/34646267](https://www.ncbi.nlm.nih.gov/pubmed/34646267)\nFurer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., . . . Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis, 80(10), 1330-1338. doi:10.1136/annrheumdis-2021-220647.\n[https://www.ncbi.nlm.nih.gov/pubmed/34127481](https://www.ncbi.nlm.nih.gov/pubmed/34127481)\nGalindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in Children: Clinical Manifestations and Pharmacologic Interventions Including Vaccine Trials. Pediatr Clin North Am, 68(5), 961-976. doi:10.1016/j.pcl.2021.05.004.\n[https://www.ncbi.nlm.nih.gov/pubmed/34538306](https://www.ncbi.nlm.nih.gov/pubmed/34538306)\nGargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., . . . Oliver, S. E. (2021). Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices \u2013 United States, June 2021. MMWR Morb Mortal Wkly Rep, 70(27), 977-982. doi:10.15585/mmwr.mm7027e2.\n[https://www.ncbi.nlm.nih.gov/pubmed/34237049](https://www.ncbi.nlm.nih.gov/pubmed/34237049)\nGatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel), 9(1). doi:10.3390/vaccines9010019.\n[https://www.ncbi.nlm.nih.gov/pubmed/33406694](https://www.ncbi.nlm.nih.gov/pubmed/33406694)\nGautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T., & Al\u2019Aref, S. (2021). A Late Presentation of COVID-19 Vaccine-Induced Myocarditis. Cureus, 13(9), e17890. doi:10.7759/cureus.17890.\n[https://www.ncbi.nlm.nih.gov/pubmed/34660088](https://www.ncbi.nlm.nih.gov/pubmed/34660088)\nGellad, W. F. (2021). Myocarditis after vaccination against covid-19. BMJ, 375, n3090. doi:10.1136/bmj.n3090.\n[https://www.ncbi.nlm.nih.gov/pubmed/34916217](https://www.ncbi.nlm.nih.gov/pubmed/34916217)\nGreenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., . . . Golden, D. B. K. (2021). The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract, 9(10), 3546-3567. doi:10.1016/j.jaip.2021.06.006.\n[https://www.ncbi.nlm.nih.gov/pubmed/34153517](https://www.ncbi.nlm.nih.gov/pubmed/34153517)\nHaaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., . . . Tanner, F. C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Med Wkly, 151, w30087. doi:10.4414/smw.2021.w30087.\n[https://www.ncbi.nlm.nih.gov/pubmed/34668687](https://www.ncbi.nlm.nih.gov/pubmed/34668687)\nHasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G., & Prabhu, S. D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord, 21(1), 375. doi:10.1186/s12872-021-02183-3.\n[https://www.ncbi.nlm.nih.gov/pubmed/34348657](https://www.ncbi.nlm.nih.gov/pubmed/34348657)\nHause, A. M., Gee, J., Baggs, J., Abara, W. E., Marquez, P., Thompson, D., . . . Shay, D. K. (2021). COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years \u2013 United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep, 70(31), 1053-1058. doi:10.15585/mmwr.mm7031e1.\n[https://www.ncbi.nlm.nih.gov/pubmed/34351881](https://www.ncbi.nlm.nih.gov/pubmed/34351881)\nHelms, J. M., Ansteatt, K. T., Roberts, J. C., Kamatam, S., Foong, K. S., Labayog, J. S., & Tarantino, M. D. (2021). Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine. J Blood Med, 12, 221-224. doi:10.2147/JBM.S307047.\n[https://www.ncbi.nlm.nih.gov/pubmed/33854395](https://www.ncbi.nlm.nih.gov/pubmed/33854395)\nHippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., . . . Coupland, C. A. C. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ, 374, n1931. doi:10.1136/bmj.n1931.\n[https://www.ncbi.nlm.nih.gov/pubmed/34446426](https://www.ncbi.nlm.nih.gov/pubmed/34446426)\nHo, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K., & Poh, K. K. (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore Med J. doi:10.11622/smedj.2021210.\n[https://www.ncbi.nlm.nih.gov/pubmed/34808708](https://www.ncbi.nlm.nih.gov/pubmed/34808708)\nIguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report. Drug Saf, 44(11), 1209-1214. doi:10.1007/s40264-021-01104-9.\n[https://www.ncbi.nlm.nih.gov/pubmed/34347278](https://www.ncbi.nlm.nih.gov/pubmed/34347278)\nIn brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines. (2021). Med Lett Drugs Ther, 63(1629), e9. Retrieved from\n[https://www.ncbi.nlm.nih.gov/pubmed/34544112https://www.ncbi.nlm.nih.gov/pubmed/34544112](https://www.ncbi.nlm.nih.gov/pubmed/34544112https:/www.ncbi.nlm.nih.gov/pubmed/34544112)\nIoannou, A. (2021a). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM. doi:10.1093/qjmed/hcab231.\n[https://www.ncbi.nlm.nih.gov/pubmed/34463755](https://www.ncbi.nlm.nih.gov/pubmed/34463755)\nIoannou, A. (2021b). T2 mapping should be utilised in cases of suspected myocarditis to confirm an acute inflammatory process. QJM. doi:10.1093/qjmed/hcab326.\n[https://www.ncbi.nlm.nih.gov/pubmed/34931681](https://www.ncbi.nlm.nih.gov/pubmed/34931681)\nIsaak, A., Feisst, A., & Luetkens, J. A. (2021). Myocarditis Following COVID-19 Vaccination. Radiology, 301(1), E378-E379. doi:10.1148/radiol.2021211766.\n[https://www.ncbi.nlm.nih.gov/pubmed/34342500](https://www.ncbi.nlm.nih.gov/pubmed/34342500)\nIstampoulouoglou, I., Dimitriou, G., Spani, S., Christ, A., Zimmermanns, B., Koechlin, S., . . . Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Glob Cardiol Sci Pract, 2021(3), e202118. doi:10.21542/gcsp.2021.18.\n[https://www.ncbi.nlm.nih.gov/pubmed/34805376](https://www.ncbi.nlm.nih.gov/pubmed/34805376)\nJaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., . . . La Scola, B. (2021). High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2. Viruses, 13(11). doi:10.3390/v13112177.\n[https://www.ncbi.nlm.nih.gov/pubmed/34834983](https://www.ncbi.nlm.nih.gov/pubmed/34834983)\nJain, S. S., Steele, J. M., Fonseca, B., Huang, S., Shah, S., Maskatia, S. A., . . . Grosse-Wortmann, L. (2021). COVID-19 Vaccination-Associated Myocarditis in Adolescents. Pediatrics, 148(5). doi:10.1542/peds.2021-053427.\n[https://www.ncbi.nlm.nih.gov/pubmed/34389692](https://www.ncbi.nlm.nih.gov/pubmed/34389692)\nJhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., . . . Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc, 10(10), 937-939. doi:10.1093/jpids/piab061.\n[https://www.ncbi.nlm.nih.gov/pubmed/34270752](https://www.ncbi.nlm.nih.gov/pubmed/34270752)\nKaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circ J. doi:10.1253/circj.CJ-21-0818.\n[https://www.ncbi.nlm.nih.gov/pubmed/34744118](https://www.ncbi.nlm.nih.gov/pubmed/34744118)\nKaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C., . . . Panza, J. A. (2021). Myocarditis following COVID-19 vaccination. Int J Cardiol Heart Vasc, 36, 100872. doi:10.1016/j.ijcha.2021.100872.\n[https://www.ncbi.nlm.nih.gov/pubmed/34568540](https://www.ncbi.nlm.nih.gov/pubmed/34568540)\nKhogali, F., & Abdelrahman, R. (2021). Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination. Cureus, 13(7), e16590. doi:10.7759/cureus.16590.\n[https://www.ncbi.nlm.nih.gov/pubmed/34447639](https://www.ncbi.nlm.nih.gov/pubmed/34447639)\nKim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., . . . Kim, R. J. (2021). Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol, 6(10), 1196-1201. doi:10.1001/jamacardio.2021.2828.\n[https://www.ncbi.nlm.nih.gov/pubmed/34185046](https://www.ncbi.nlm.nih.gov/pubmed/34185046)\nKim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination. J Korean Med Sci, 36(32), e229. doi:10.3346/jkms.2021.36.e229.\n[https://www.ncbi.nlm.nih.gov/pubmed/34402228](https://www.ncbi.nlm.nih.gov/pubmed/34402228)\nKing, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Cuervo Pardo, L., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. Am Heart J Plus, 8, 100042. doi:10.1016/j.ahjo.2021.100042.\n[https://www.ncbi.nlm.nih.gov/pubmed/34396358](https://www.ncbi.nlm.nih.gov/pubmed/34396358)\nKlein, N. P., Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, K. E., . . . Weintraub, E. S. (2021). Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA, 326(14), 1390-1399. doi:10.1001/jama.2021.15072.\n[https://www.ncbi.nlm.nih.gov/pubmed/34477808](https://www.ncbi.nlm.nih.gov/pubmed/34477808)\nKlimek, L., Bergmann, K. C., Brehler, R., Pfutzner, W., Zuberbier, T., Hartmann, K., . . . Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and OGAI. Allergo J Int, 1-17. doi:10.1007/s40629-021-00165-7.\n[https://www.ncbi.nlm.nih.gov/pubmed/33898162](https://www.ncbi.nlm.nih.gov/pubmed/33898162)\nKlimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., . . . Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA). Allergo J Int, 30(2), 51-55. doi:10.1007/s40629-020-00160-4.\n[https://www.ncbi.nlm.nih.gov/pubmed/33643776](https://www.ncbi.nlm.nih.gov/pubmed/33643776)\nKohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A., . . . Ang, J. Y. (2021). mRNA Coronavirus-19 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. J Pediatr. doi:10.1016/j.jpeds.2021.12.025.\n[https://www.ncbi.nlm.nih.gov/pubmed/34952008](https://www.ncbi.nlm.nih.gov/pubmed/34952008)\nKostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021a). Erratum to \u00abWhy are we vaccinating children against COVID-19?\u00bb [Toxicol. Rep. 8C (2021) 1665-1684 / 1193]. Toxicol Rep, 8, 1981. doi:10.1016/j.toxrep.2021.10.003.\n[https://www.ncbi.nlm.nih.gov/pubmed/34642628](https://www.ncbi.nlm.nih.gov/pubmed/34642628)\nKostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021b). Why are we vaccinating children against COVID-19? Toxicol Rep, 8, 1665-1684. doi:10.1016/j.toxrep.2021.08.010.\n[https://www.ncbi.nlm.nih.gov/pubmed/34540594](https://www.ncbi.nlm.nih.gov/pubmed/34540594)\nKremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., . . . Group, C.-N.-S. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial. Wien Klin Wochenschr, 133(17-18), 931-941. doi:10.1007/s00508-021-01922-y.\n[https://www.ncbi.nlm.nih.gov/pubmed/34378087](https://www.ncbi.nlm.nih.gov/pubmed/34378087)\nKustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., . . . Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nat Med, 27(8), 1379-1384. doi:10.1038/s41591-021-01413-7.\n[https://www.ncbi.nlm.nih.gov/pubmed/34127854](https://www.ncbi.nlm.nih.gov/pubmed/34127854)\nKwan, M. Y. W., Chua, G. T., Chow, C. B., Tsao, S. S. L., To, K. K. W., Yuen, K. Y., . . . Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-327. doi:10.12809/hkmj215120.\n[https://www.ncbi.nlm.nih.gov/pubmed/34393110](https://www.ncbi.nlm.nih.gov/pubmed/34393110)\nLee, E., Chew, N. W. S., Ng, P., & Yeo, T. J. (2021). Reply to \u00abLetter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination\u00bb. QJM. doi:10.1093/qjmed/hcab232.\n[https://www.ncbi.nlm.nih.gov/pubmed/34463770](https://www.ncbi.nlm.nih.gov/pubmed/34463770)\nLee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., . . . Bussel, J. B. (2021). Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol, 96(5), 534-537. doi:10.1002/ajh.26132.\n[https://www.ncbi.nlm.nih.gov/pubmed/33606296](https://www.ncbi.nlm.nih.gov/pubmed/33606296)\nLevin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A., . . . Gordon, B. (2021). Myocarditis following COVID-19 vaccination \u2013 A case series. Vaccine, 39(42), 6195-6200. doi:10.1016/j.vaccine.2021.09.004.\n[https://www.ncbi.nlm.nih.gov/pubmed/34535317](https://www.ncbi.nlm.nih.gov/pubmed/34535317)\nLi, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., . . . Zhu, F. (2021). Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nat Med, 27(6), 1062-1070. doi:10.1038/s41591-021-01330-9.\n[https://www.ncbi.nlm.nih.gov/pubmed/33888900](https://www.ncbi.nlm.nih.gov/pubmed/33888900)\nLi, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. J Pers Med, 11(11). doi:10.3390/jpm11111106.\n[https://www.ncbi.nlm.nih.gov/pubmed/34834458](https://www.ncbi.nlm.nih.gov/pubmed/34834458)\nLim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Front Cardiovasc Med, 8, 758996. doi:10.3389/fcvm.2021.758996.\n[https://www.ncbi.nlm.nih.gov/pubmed/34778411](https://www.ncbi.nlm.nih.gov/pubmed/34778411)\nLong, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. J Pediatr, 238, 5. doi:10.1016/j.jpeds.2021.07.057.\n[https://www.ncbi.nlm.nih.gov/pubmed/34332972](https://www.ncbi.nlm.nih.gov/pubmed/34332972)\nLuk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., . . . McDonald, M. (2021). Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers. Can J Cardiol, 37(10), 1629-1634. doi:10.1016/j.cjca.2021.08.001.\n[https://www.ncbi.nlm.nih.gov/pubmed/34375696](https://www.ncbi.nlm.nih.gov/pubmed/34375696)\nMadelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., . . . Eberhardt, C. S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clin Infect Dis. doi:10.1093/cid/ciab954.\n[https://www.ncbi.nlm.nih.gov/pubmed/34791081](https://www.ncbi.nlm.nih.gov/pubmed/34791081)\nMangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Rep Pediatr, 2021, 6901131. doi:10.1155/2021/6901131.\n[https://www.ncbi.nlm.nih.gov/pubmed/34676123](https://www.ncbi.nlm.nih.gov/pubmed/34676123)\nMark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., . . . Alexander, S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase. Pediatr Blood Cancer, 68(11), e29295. doi:10.1002/pbc.29295.\n[https://www.ncbi.nlm.nih.gov/pubmed/34398511](https://www.ncbi.nlm.nih.gov/pubmed/34398511)\nMartins-Filho, P. R., Quintans-Junior, L. J., de Souza Araujo, A. A., Sposato, K. B., Souza Tavares, C. S., Gurgel, R. Q., . . . Santos, V. S. (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. doi:10.1016/j.puhe.2020.11.005.\n[https://www.ncbi.nlm.nih.gov/pubmed/33316478](https://www.ncbi.nlm.nih.gov/pubmed/33316478)\nMcLean, K., & Johnson, T. J. (2021). Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report. Acad Emerg Med, 28(8), 918-921. doi:10.1111/acem.14322.\n[https://www.ncbi.nlm.nih.gov/pubmed/34133825](https://www.ncbi.nlm.nih.gov/pubmed/34133825)\nMevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., . . . Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. N Engl J Med, 385(23), 2140-2149. doi:10.1056/NEJMoa2109730.\n[https://www.ncbi.nlm.nih.gov/pubmed/34614328](https://www.ncbi.nlm.nih.gov/pubmed/34614328)\nMinocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent. J Pediatr, 238, 321-323. doi:10.1016/j.jpeds.2021.06.035.\n[https://www.ncbi.nlm.nih.gov/pubmed/34166671](https://www.ncbi.nlm.nih.gov/pubmed/34166671)\nMizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A., . . . Patalon, T. (2021). Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. Nat Commun, 12(1), 6379. doi:10.1038/s41467-021-26672-3.\n[https://www.ncbi.nlm.nih.gov/pubmed/34737312](https://www.ncbi.nlm.nih.gov/pubmed/34737312)\nMoffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus Transcriptome in Pediatric Soft Tissue Abscesses and Comparison to Murine Infections. Infect Immun, 89(4). doi:10.1128/IAI.00715-20.\n[https://www.ncbi.nlm.nih.gov/pubmed/33526560](https://www.ncbi.nlm.nih.gov/pubmed/33526560)\nMohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S., & Kofoed, P. E. (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports. BMC Infect Dis, 21(1), 1264. doi:10.1186/s12879-021-06949-0.\n[https://www.ncbi.nlm.nih.gov/pubmed/34930152](https://www.ncbi.nlm.nih.gov/pubmed/34930152)\nMontgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., . . . Cooper, L. T., Jr. (2021). Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol, 6(10), 1202-1206. doi:10.1001/jamacardio.2021.2833.\n[https://www.ncbi.nlm.nih.gov/pubmed/34185045](https://www.ncbi.nlm.nih.gov/pubmed/34185045)\nMurakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H., . . . Ikeda, T. (2021). Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series. Intern Med. doi:10.2169/internalmedicine.8731-21.\n[https://www.ncbi.nlm.nih.gov/pubmed/34840235](https://www.ncbi.nlm.nih.gov/pubmed/34840235)\nNagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y., . . . Kaneko, Y. (2021). Acute Myocarditis Associated with COVID-19 Vaccination: A Case Report. J Cardiol Cases. doi:10.1016/j.jccase.2021.11.006.\n[https://www.ncbi.nlm.nih.gov/pubmed/34876937](https://www.ncbi.nlm.nih.gov/pubmed/34876937)\nNtouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., . . . Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clin Immunol, 229, 108765. doi:10.1016/j.clim.2021.108765.\n[https://www.ncbi.nlm.nih.gov/pubmed/34089859](https://www.ncbi.nlm.nih.gov/pubmed/34089859)\nNygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., . . . Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. Pediatr Infect Dis J, 41(1), e25-e28. doi:10.1097/INF.0000000000003389.\n[https://www.ncbi.nlm.nih.gov/pubmed/34889875](https://www.ncbi.nlm.nih.gov/pubmed/34889875)\nOberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., . . . Hofmann, M. (2021). Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. doi:10.1038/s41586-021-03841-4.\n[https://www.ncbi.nlm.nih.gov/pubmed/34320609](https://www.ncbi.nlm.nih.gov/pubmed/34320609)\nPark, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., . . . Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. J Korean Med Sci, 36(32), e232. doi:10.3346/jkms.2021.36.e232.\n[https://www.ncbi.nlm.nih.gov/pubmed/34402230](https://www.ncbi.nlm.nih.gov/pubmed/34402230)\nPark, J., Brekke, D. R., & Bratincsak, A. (2021). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiol Young, 1-4. doi:10.1017/S1047951121002547.\n[https://www.ncbi.nlm.nih.gov/pubmed/34180390](https://www.ncbi.nlm.nih.gov/pubmed/34180390)\nPatel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. J Cardiovasc Magn Reson, 23(1), 101. doi:10.1186/s12968-021-00795-4.\n[https://www.ncbi.nlm.nih.gov/pubmed/34496880](https://www.ncbi.nlm.nih.gov/pubmed/34496880)\nPatone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., . . . Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. doi:10.1038/s41591-021-01630-0.\n[https://www.ncbi.nlm.nih.gov/pubmed/34907393](https://www.ncbi.nlm.nih.gov/pubmed/34907393)\nPatrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Rep, 16(11), 3321-3325. doi:10.1016/j.radcr.2021.07.082.\n[https://www.ncbi.nlm.nih.gov/pubmed/34367386](https://www.ncbi.nlm.nih.gov/pubmed/34367386)\nPerez, Y., Levy, E. R., Joshi, A. Y., Virk, A., Rodriguez-Porcel, M., Johnson, M., . . . Swift, M. D. (2021). Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination. Clin Infect Dis. doi:10.1093/cid/ciab926.\n[https://www.ncbi.nlm.nih.gov/pubmed/34734240](https://www.ncbi.nlm.nih.gov/pubmed/34734240)\nPerrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., . . . Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Med, 63(3), 324-331. doi:10.23736/S0031-0808.21.04435-9.\n[https://www.ncbi.nlm.nih.gov/pubmed/34738774](https://www.ncbi.nlm.nih.gov/pubmed/34738774)\nPinana, J. L., Lopez-Corral, L., Martino, R., Montoro, J., Vazquez, L., Perez, A., . . . Cell Therapy, G. (2022). SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. Am J Hematol, 97(1), 30-42. doi:10.1002/ajh.26385.\n[https://www.ncbi.nlm.nih.gov/pubmed/34695229](https://www.ncbi.nlm.nih.gov/pubmed/34695229)\nRevon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., . . . Andre, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. Eur J Cancer, 154, 30-34. doi:10.1016/j.ejca.2021.06.002.\n[https://www.ncbi.nlm.nih.gov/pubmed/34233234](https://www.ncbi.nlm.nih.gov/pubmed/34233234)\nSanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Cardiac MRI Assessment of Nonischemic Myocardial Inflammation: State of the Art Review and Update on Myocarditis Associated with COVID-19 Vaccination. Radiol Cardiothorac Imaging, 3(6), e210252. doi:10.1148/ryct.210252.\n[https://www.ncbi.nlm.nih.gov/pubmed/34934954](https://www.ncbi.nlm.nih.gov/pubmed/34934954)\nSchauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Mallenahalli Chikkabyrappa, S., & Portman, M. A. (2021). Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr, 238, 317-320. doi:10.1016/j.jpeds.2021.06.083.\n[https://www.ncbi.nlm.nih.gov/pubmed/34228985](https://www.ncbi.nlm.nih.gov/pubmed/34228985)\nSchneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., . . . Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. Int J Legal Med, 135(6), 2335-2345. doi:10.1007/s00414-021-02706-9.\n[https://www.ncbi.nlm.nih.gov/pubmed/34591186](https://www.ncbi.nlm.nih.gov/pubmed/34591186)\nSchramm, R., Costard-Jackle, A., Rivinius, R., Fischer, B., Muller, B., Boeken, U., . . . Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clin Res Cardiol, 110(8), 1142-1149. doi:10.1007/s00392-021-01880-5.\n[https://www.ncbi.nlm.nih.gov/pubmed/34241676](https://www.ncbi.nlm.nih.gov/pubmed/34241676)\nSessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. J Clin Med, 10(24). doi:10.3390/jcm10245876.\n[https://www.ncbi.nlm.nih.gov/pubmed/34945172](https://www.ncbi.nlm.nih.gov/pubmed/34945172)\nSharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Front Immunol, 12, 714170. doi:10.3389/fimmu.2021.714170.\n[https://www.ncbi.nlm.nih.gov/pubmed/34707602](https://www.ncbi.nlm.nih.gov/pubmed/34707602)\nShay, D. K., Gee, J., Su, J. R., Myers, T. R., Marquez, P., Liu, R., . . . Shimabukuro, T. T. (2021). Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine \u2013 United States, March-April 2021. MMWR Morb Mortal Wkly Rep, 70(18), 680-684. doi:10.15585/mmwr.mm7018e2.\n[https://www.ncbi.nlm.nih.gov/pubmed/33956784](https://www.ncbi.nlm.nih.gov/pubmed/33956784)\nShazley, O., & Alshazley, M. (2021). A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study. Cureus, 13(7), e16383. doi:10.7759/cureus.16383.\n[https://www.ncbi.nlm.nih.gov/pubmed/34408937](https://www.ncbi.nlm.nih.gov/pubmed/34408937)\nShiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M., . . . Hamdan, A. (2021). Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. Eur Heart J Cardiovasc Imaging. doi:10.1093/ehjci/jeab230.\n[https://www.ncbi.nlm.nih.gov/pubmed/34739045](https://www.ncbi.nlm.nih.gov/pubmed/34739045)\nSimone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y., Lewin, B., & Lee, M. S. (2021). Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older. JAMA Intern Med, 181(12), 1668-1670. doi:10.1001/jamainternmed.2021.5511.\n[https://www.ncbi.nlm.nih.gov/pubmed/34605853](https://www.ncbi.nlm.nih.gov/pubmed/34605853)\nSinger, M. E., Taub, I. B., & Kaelber, D. C. (2021). Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. medRxiv. doi:10.1101/2021.07.23.21260998.\n[https://www.ncbi.nlm.nih.gov/pubmed/34341797](https://www.ncbi.nlm.nih.gov/pubmed/34341797)\nSmith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., . . . Fraser, L. K. (2021). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med. doi:10.1038/s41591-021-01578-1.\n[https://www.ncbi.nlm.nih.gov/pubmed/34764489](https://www.ncbi.nlm.nih.gov/pubmed/34764489)\nSnapiri, O., Rosenberg Danziger, C., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., . . . Bilavsky, E. (2021). Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine. Pediatr Infect Dis J, 40(10), e360-e363. doi:10.1097/INF.0000000000003235.\n[https://www.ncbi.nlm.nih.gov/pubmed/34077949](https://www.ncbi.nlm.nih.gov/pubmed/34077949)\nSpinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Munoz, F. M., & Devaraj, S. (2021). SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report. J Heart Lung Transplant. doi:10.1016/j.healun.2021.11.001.\n[https://www.ncbi.nlm.nih.gov/pubmed/34911654](https://www.ncbi.nlm.nih.gov/pubmed/34911654)\nStarekova, J., Bluemke, D. A., Bradham, W. S., Grist, T. M., Schiebler, M. L., & Reeder, S. B. (2021). Myocarditis Associated with mRNA COVID-19 Vaccination. Radiology, 301(2), E409-E411. doi:10.1148/radiol.2021211430.\n[https://www.ncbi.nlm.nih.gov/pubmed/34282971](https://www.ncbi.nlm.nih.gov/pubmed/34282971)\nSulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review. Cardiovasc Revasc Med. doi:10.1016/j.carrev.2021.08.012.\n[https://www.ncbi.nlm.nih.gov/pubmed/34420869](https://www.ncbi.nlm.nih.gov/pubmed/34420869)\nTailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. Eur Heart J Case Rep, 5(8), ytab319. doi:10.1093/ehjcr/ytab319.\n[https://www.ncbi.nlm.nih.gov/pubmed/34514306](https://www.ncbi.nlm.nih.gov/pubmed/34514306)\nTakeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M., & Shikama, N. (2021). Eosinophilic Myocarditis Following Coronavirus Disease 2019 (COVID-19) Vaccination. Circ J. doi:10.1253/circj.CJ-21-0935.\n[https://www.ncbi.nlm.nih.gov/pubmed/34955479](https://www.ncbi.nlm.nih.gov/pubmed/34955479)\nTeam, C. C.-R., Food, & Drug, A. (2021). Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine \u2013 United States, December 14-23, 2020. MMWR Morb Mortal Wkly Rep, 70(2), 46-51. doi:10.15585/mmwr.mm7002e1.\n[https://www.ncbi.nlm.nih.gov/pubmed/33444297](https://www.ncbi.nlm.nih.gov/pubmed/33444297)\nThompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., . . . Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. N Engl J Med, 385(4), 320-329. doi:10.1056/NEJMoa2107058.\n[https://www.ncbi.nlm.nih.gov/pubmed/34192428](https://www.ncbi.nlm.nih.gov/pubmed/34192428)\nTinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G., . . . Lourenco, A. (2021). Perimyocarditis Following COVID-19 Vaccination. Clin Med Insights Cardiol, 15, 11795468211056634. doi:10.1177/11795468211056634.\n[https://www.ncbi.nlm.nih.gov/pubmed/34866957](https://www.ncbi.nlm.nih.gov/pubmed/34866957)\nTruong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., . . . Newburger, J. W. (2021). Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults. Circulation. doi:10.1161/CIRCULATIONAHA.121.056583.\n[https://www.ncbi.nlm.nih.gov/pubmed/34865500](https://www.ncbi.nlm.nih.gov/pubmed/34865500)\nTutor, A., Unis, G., Ruiz, B., Bolaji, O. A., & Bob-Manuel, T. (2021). Spectrum of Suspected Cardiomyopathy Due to COVID-19: A Case Series. Curr Probl Cardiol, 46(10), 100926. doi:10.1016/j.cpcardiol.2021.100926.\n[https://www.ncbi.nlm.nih.gov/pubmed/34311983](https://www.ncbi.nlm.nih.gov/pubmed/34311983)\nUmei, T. C., Kishino, Y., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC Open. doi:10.1016/j.cjco.2021.12.002.\n[https://www.ncbi.nlm.nih.gov/pubmed/34904134](https://www.ncbi.nlm.nih.gov/pubmed/34904134)\nVidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines. Cureus, 13(6), e15576. doi:10.7759/cureus.15576.\n[https://www.ncbi.nlm.nih.gov/pubmed/34277198](https://www.ncbi.nlm.nih.gov/pubmed/34277198)\nVisclosky, T., Theyyunni, N., Klekowski, N., & Bradin, S. (2021). Myocarditis Following mRNA COVID-19 Vaccine. Pediatr Emerg Care, 37(11), 583-584. doi:10.1097/PEC.0000000000002557.\n[https://www.ncbi.nlm.nih.gov/pubmed/34731877](https://www.ncbi.nlm.nih.gov/pubmed/34731877)\nWarren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., . . . Nadeau, K. C. (2021). Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. JAMA Netw Open, 4(9), e2125524. doi:10.1001/jamanetworkopen.2021.25524.\n[https://www.ncbi.nlm.nih.gov/pubmed/34533570](https://www.ncbi.nlm.nih.gov/pubmed/34533570)\nWatkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. Am J Emerg Med, 50, 815 e811-815 e812. doi:10.1016/j.ajem.2021.06.051.\n[https://www.ncbi.nlm.nih.gov/pubmed/34229940](https://www.ncbi.nlm.nih.gov/pubmed/34229940)\nWeitzman, E. R., Sherman, A. C., & Levy, O. (2021). SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Front Public Health, 9, 695807. doi:10.3389/fpubh.2021.695807.\n[https://www.ncbi.nlm.nih.gov/pubmed/34336774](https://www.ncbi.nlm.nih.gov/pubmed/34336774)\nWelsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. doi:10.1016/j.vaccine.2021.04.054.\n[https://www.ncbi.nlm.nih.gov/pubmed/34006408](https://www.ncbi.nlm.nih.gov/pubmed/34006408)\nWitberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y., . . . Kornowski, R. (2021). Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. N Engl J Med, 385(23), 2132-2139. doi:10.1056/NEJMoa2110737.\n[https://www.ncbi.nlm.nih.gov/pubmed/34614329](https://www.ncbi.nlm.nih.gov/pubmed/34614329)\nZimmermann, P., & Curtis, N. (2020). Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. doi:10.1136/archdischild-2020-320338.\n[https://www.ncbi.nlm.nih.gov/pubmed/33262177](https://www.ncbi.nlm.nih.gov/pubmed/33262177)\nGeert Vanden Bossche, cient\u00edfico y vacun\u00f3logo advirte sobre el gran peligro de la vacunaci\u00f3n masiva en medio de una propagaci\u00f3n viral en la poblaci\u00f3n general, lo que solo crea la presi\u00f3n inmunol\u00f3gica para seleccionar cepas m\u00e1s virulentas y contagiosas.\n[https://www.bitchute.com/video/uT8ErRzTsy9V/](https://www.bitchute.com/video/uT8ErRzTsy9V/)\nColabore con Nosotros es la \u00fanica manera que tenemos de poder seguir con esta base de datos online, gracias\nBill Gates pose\u00eda una gran participaci\u00f3n en el fabricante de remdesivir, Gilead. [124] Los propios estudios de la OMS mostraron claramente, como incluso la OMS reconoci\u00f3, que el remdesivir no era \u00fatil contra el COVID. [125] Peor a\u00fan, la extrema toxicidad del f\u00e1rmaco (los efectos secundarios del remdesivir imitan los s\u00edntomas de la \u00faltima etapa del COVID [126 , 127] ) en realidad puede empeorar la gravedad de la enfermedad. [128] Para superar estos obst\u00e1culos, el Dr. Fauci financi\u00f3 y manipul\u00f3 una serie de estudios defectuosos para sugerir, enga\u00f1osamente, que remdesivir podr\u00eda reducir levemente la cantidad de d\u00edas que un paciente permanecer\u00eda en el hospital. [129] Los estudios mucho m\u00e1s amplios de la OMS demostraron que no hubo reducci\u00f3n en la duraci\u00f3n de la estancia hospitalaria. Sin embargo, utilizando su \u201cinvestigaci\u00f3n\u201d descaradamente orquestada, el Dr. Fauci forz\u00f3 la aprobaci\u00f3n de remdesivir a trav\u00e9s de la FDA como \u201cest\u00e1ndar de atenci\u00f3n\u201d para COVID. Al mismo tiempo, el Dr. Fauci y Bill Gates estaban financiando y promoviendo estudios para desacreditar la cloroquina y la hidroxicloroquina y sabotear la ivermectina, dos remedios efectivos contra el COVID que representaban una amenaza existencial para el remdesivir y toda la empresa de vacunas contra el COVID de Fauci/Gates.\nExtractado de el libro de Robert Kennedy Jr. sobre Fauci, ver mas en : https://cienciaysaludnatural.com/la-historia-criminal-del-dr-anthony-fauci-documentada-en-un-libro-de-robert-kennedy-jr/\n- Gilead Sciences, Inc., U.S. Securities and Exchange Commission, Form 10-K (Dec. 31, 2005), sec.gov/Archives/edgar/data/882095/000119312506045128/d10k.htm\n- World Health Organization, \u201cWHO recommends against the use of remdesivir in COVID-19 patients\u201d (Nov 20, 2020), who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients\n- Drugs.com, Remdesivir Side Effects (Feb 13, 2021), drugs.com/sfx/remdesivir-side-effects.html\n- Centers for Disease Control and Prevention, Symptoms of COVID-19 (Feb. 22, 2021), cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html\n- Jason D. Goldman et al., \u201cRemdesivir for 5 or 10 Days in Patients with Severe Covid-19,\u201d New England Journal of Medicine (May 27, 2020), nejm.org/doi/full/10.1056/NEJMoa2015301\n- John H. Beigel et al., \u201cRemdesivir for the Treatment of Covid-19\u2014Final Report,\u201d New England Journal of Medicine (Oct. 8, 2020), nejm.org/doi/10.1056/NEJMoa2007764", "language": null, "image": "https://cienciaysaludnatural.com/wp-content/uploads/2021/12/chico-en-caverna-porta.jpg", "pagetype": "article", "links": ["https://cienciaysaludnatural.com/feed/", "https://www.facebook.com/cienciaysaludnaturalcom", "https://twitter.com/cienciaysaludn1", "https://cienciaysaludnatural.com/quienes-somos/", "https://cienciaysaludnatural.com/contactenos/", "https://cienciaysaludnatural.com/participe/", "https://cienciaysaludnatural.com/feed/", "https://www.facebook.com/cienciaysaludnaturalcom", "https://twitter.com/cienciaysaludn1", "#", "https://cienciaysaludnatural.com/", "https://reportar.cienciaysaludnatural.com/", "https://cienciaysaludnatural.com/", "https://cienciaysaludnatural.com/", "https://red.cienciaysaludnatural.com", "#", "https://cienciaysaludnatural.com/category/vacunas/", "http://reportar.cienciaysaludnatural.com/", "https://cienciaysaludnatural.com/estudios-sobre-vacunas/", "https://cienciaysaludnatural.com/category/seguridad/", "https://cienciaysaludnatural.com/el-aluminio-en-las-vacunas-pueden-causar-autismo/", "https://cienciaysaludnatural.com/category/polio/", "https://cienciaysaludnatural.com/category/hepatitis-b/", "https://cienciaysaludnatural.com/vacuna-de-la-gripe-mas-riesgos-que-beneficios/", "https://cienciaysaludnatural.com/vitamina-k-uso-y-riesgos/", "https://cienciaysaludnatural.com/vacunas-prospectos/", "https://cienciaysaludnatural.com/category/inmunidad/", "https://www.bitchute.com/channel/IUdbxstFCUXH/", "https://cienciaysaludnatural.com/estudios-cientificos-sobre-danos-de-vacunas/", "https://cienciaysaludnatural.com/estudios-sobre-vacunas/", "https://cienciaysaludnatural.com/listado-de-estudios-cientificos/", "http://reportar.cienciaysaludnatural.com/", "https://reportar.cienciaysaludnatural.com/como-se-reporta-en-el-sistema/", "https://cienciaysaludnatural.com/testimonios-de-afectados-por-vacunas/", "https://cienciaysaludnatural.com/eventos-adversos-de-vacunas/", "https://cienciaysaludnatural.com/mi-cuenta/", "https://red.cienciaysaludnatural.com/cursos/", "https://cienciaysaludnatural.com/hierbas/", "https://cienciaysaludnatural.com/plantas-medicinales-usos/", "https://cienciaysaludnatural.com/plantas-medicinales/", "https://cienciaysaludnatural.com/colaboracion/", "#", "https://cienciaysaludnatural.com/quienes-somos/", "https://cienciaysaludnatural.com/contactenos/", "https://cienciaysaludnatural.com/terminos-del-servicio/", "https://cienciaysaludnatural.com/", "https://cienciaysaludnatural.com/category/efectos-adversos/", "https://cienciaysaludnatural.com/colaboracion/", "https://cienciaysaludnatural.com/category/efectos-adversos/", "https://cienciaysaludnatural.com/category/menores/", "https://cienciaysaludnatural.com/category/seguridad/", "https://cienciaysaludnatural.com/category/vacunas/", "#", "https://cienciaysaludnatural.com/wp-content/uploads/2021/12/chico-en-caverna-porta.jpg", "https://cienciaysaludnatural.com/colaboracion/", "https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf", "https://www.canadiancovidcarealliance.org/wp-content/uploads/2021/12/The-COVID-19-Inoculations-More-Harm-Than-Good-REV-Dec-16-2021.pdf", "https://www.canadiancovidcarealliance.org/", "https://www.canadiancovidcarealliance.org/wp-content/uploads/2021/12/The-COVID-19-Inoculations-More-Harm-Than-Good-REV-Dec-16-2021.pdf", "https://www.canadiancovidcarealliance.org/", "https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm", "https://www.fda.gov/media/144416/download", "https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data/", "https://www.ncbi.nlm.nih.gov/pubmed/34416319", "https://www.ncbi.nlm.nih.gov/pubmed/34092429", "https://www.ncbi.nlm.nih.gov/pubmed/34025885", "https://www.ncbi.nlm.nih.gov/pubmed/34586408", "https://www.ncbi.nlm.nih.gov/pubmed/34756746", "https://www.ncbi.nlm.nih.gov/pubmed/34432976", "https://www.ncbi.nlm.nih.gov/pubmed/34754400", "https://www.ncbi.nlm.nih.gov/pubmed/34281357", "https://www.ncbi.nlm.nih.gov/pubmed/34835284", "https://www.ncbi.nlm.nih.gov/pubmed/34366403", "https://www.ncbi.nlm.nih.gov/pubmed/34564344", "https://www.ncbi.nlm.nih.gov/pubmed/34617315", "https://www.ncbi.nlm.nih.gov/pubmed/34333695", "https://www.ncbi.nlm.nih.gov/pubmed/34833382", "https://www.ncbi.nlm.nih.gov/pubmed/34704459", "https://www.ncbi.nlm.nih.gov/pubmed/34664804", "https://www.ncbi.nlm.nih.gov/pubmed/34860360", "https://www.ncbi.nlm.nih.gov/pubmed/34849657", "https://www.ncbi.nlm.nih.gov/pubmed/34933012", "https://www.ncbi.nlm.nih.gov/pubmed/34547487", "https://www.ncbi.nlm.nih.gov/pubmed/34339728", "https://www.ncbi.nlm.nih.gov/pubmed/34356586", "https://www.ncbi.nlm.nih.gov/pubmed/34219532", "https://www.ncbi.nlm.nih.gov/pubmed/34246585", "https://www.ncbi.nlm.nih.gov/pubmed/34492161", "https://www.ncbi.nlm.nih.gov/pubmed/34844930", "https://www.ncbi.nlm.nih.gov/pubmed/34487236", "https://www.ncbi.nlm.nih.gov/pubmed/34551225", "https://www.ncbi.nlm.nih.gov/pubmed/34709227", "https://www.ncbi.nlm.nih.gov/pubmed/34921468", "https://www.ncbi.nlm.nih.gov/pubmed/34824230", "https://doi.org/10.1007/s00392-020-01704-y", "https://www.ncbi.nlm.nih.gov/pubmed/34170372", "https://www.ncbi.nlm.nih.gov/pubmed/34849667", "https://www.ncbi.nlm.nih.gov/pubmed/34646267", "https://www.ncbi.nlm.nih.gov/pubmed/34127481", "https://www.ncbi.nlm.nih.gov/pubmed/34538306", "https://www.ncbi.nlm.nih.gov/pubmed/34237049", "https://www.ncbi.nlm.nih.gov/pubmed/33406694", "https://www.ncbi.nlm.nih.gov/pubmed/34660088", "https://www.ncbi.nlm.nih.gov/pubmed/34916217", "https://www.ncbi.nlm.nih.gov/pubmed/34153517", "https://www.ncbi.nlm.nih.gov/pubmed/34668687", "https://www.ncbi.nlm.nih.gov/pubmed/34348657", "https://www.ncbi.nlm.nih.gov/pubmed/34351881", "https://www.ncbi.nlm.nih.gov/pubmed/33854395", "https://www.ncbi.nlm.nih.gov/pubmed/34446426", "https://www.ncbi.nlm.nih.gov/pubmed/34808708", "https://www.ncbi.nlm.nih.gov/pubmed/34347278", "https://www.ncbi.nlm.nih.gov/pubmed/34544112https:/www.ncbi.nlm.nih.gov/pubmed/34544112", "https://www.ncbi.nlm.nih.gov/pubmed/34463755", "https://www.ncbi.nlm.nih.gov/pubmed/34931681", "https://www.ncbi.nlm.nih.gov/pubmed/34342500", "https://www.ncbi.nlm.nih.gov/pubmed/34805376", "https://www.ncbi.nlm.nih.gov/pubmed/34834983", "https://www.ncbi.nlm.nih.gov/pubmed/34389692", "https://www.ncbi.nlm.nih.gov/pubmed/34270752", "https://www.ncbi.nlm.nih.gov/pubmed/34744118", "https://www.ncbi.nlm.nih.gov/pubmed/34568540", "https://www.ncbi.nlm.nih.gov/pubmed/34447639", "https://www.ncbi.nlm.nih.gov/pubmed/34185046", "https://www.ncbi.nlm.nih.gov/pubmed/34402228", "https://www.ncbi.nlm.nih.gov/pubmed/34396358", "https://www.ncbi.nlm.nih.gov/pubmed/34477808", "https://www.ncbi.nlm.nih.gov/pubmed/33898162", "https://www.ncbi.nlm.nih.gov/pubmed/33643776", "https://www.ncbi.nlm.nih.gov/pubmed/34952008", "https://www.ncbi.nlm.nih.gov/pubmed/34642628", "https://www.ncbi.nlm.nih.gov/pubmed/34540594", "https://www.ncbi.nlm.nih.gov/pubmed/34378087", "https://www.ncbi.nlm.nih.gov/pubmed/34127854", "https://www.ncbi.nlm.nih.gov/pubmed/34393110", "https://www.ncbi.nlm.nih.gov/pubmed/34463770", "https://www.ncbi.nlm.nih.gov/pubmed/33606296", "https://www.ncbi.nlm.nih.gov/pubmed/34535317", "https://www.ncbi.nlm.nih.gov/pubmed/33888900", "https://www.ncbi.nlm.nih.gov/pubmed/34834458", "https://www.ncbi.nlm.nih.gov/pubmed/34778411", "https://www.ncbi.nlm.nih.gov/pubmed/34332972", "https://www.ncbi.nlm.nih.gov/pubmed/34375696", "https://www.ncbi.nlm.nih.gov/pubmed/34791081", "https://www.ncbi.nlm.nih.gov/pubmed/34676123", "https://www.ncbi.nlm.nih.gov/pubmed/34398511", "https://www.ncbi.nlm.nih.gov/pubmed/33316478", "https://www.ncbi.nlm.nih.gov/pubmed/34133825", "https://www.ncbi.nlm.nih.gov/pubmed/34614328", "https://www.ncbi.nlm.nih.gov/pubmed/34166671", "https://www.ncbi.nlm.nih.gov/pubmed/34737312", "https://www.ncbi.nlm.nih.gov/pubmed/33526560", "https://www.ncbi.nlm.nih.gov/pubmed/34930152", "https://www.ncbi.nlm.nih.gov/pubmed/34185045", "https://www.ncbi.nlm.nih.gov/pubmed/34840235", "https://www.ncbi.nlm.nih.gov/pubmed/34876937", "https://www.ncbi.nlm.nih.gov/pubmed/34089859", "https://www.ncbi.nlm.nih.gov/pubmed/34889875", "https://www.ncbi.nlm.nih.gov/pubmed/34320609", "https://www.ncbi.nlm.nih.gov/pubmed/34402230", "https://www.ncbi.nlm.nih.gov/pubmed/34180390", "https://www.ncbi.nlm.nih.gov/pubmed/34496880", "https://www.ncbi.nlm.nih.gov/pubmed/34907393", "https://www.ncbi.nlm.nih.gov/pubmed/34367386", "https://www.ncbi.nlm.nih.gov/pubmed/34734240", "https://www.ncbi.nlm.nih.gov/pubmed/34738774", "https://www.ncbi.nlm.nih.gov/pubmed/34695229", "https://www.ncbi.nlm.nih.gov/pubmed/34233234", "https://www.ncbi.nlm.nih.gov/pubmed/34934954", "https://www.ncbi.nlm.nih.gov/pubmed/34228985", "https://www.ncbi.nlm.nih.gov/pubmed/34591186", "https://www.ncbi.nlm.nih.gov/pubmed/34241676", "https://www.ncbi.nlm.nih.gov/pubmed/34945172", "https://www.ncbi.nlm.nih.gov/pubmed/34707602", "https://www.ncbi.nlm.nih.gov/pubmed/33956784", "https://www.ncbi.nlm.nih.gov/pubmed/34408937", "https://www.ncbi.nlm.nih.gov/pubmed/34739045", "https://www.ncbi.nlm.nih.gov/pubmed/34605853", "https://www.ncbi.nlm.nih.gov/pubmed/34341797", "https://www.ncbi.nlm.nih.gov/pubmed/34764489", "https://www.ncbi.nlm.nih.gov/pubmed/34077949", "https://www.ncbi.nlm.nih.gov/pubmed/34911654", "https://www.ncbi.nlm.nih.gov/pubmed/34282971", "https://www.ncbi.nlm.nih.gov/pubmed/34420869", "https://www.ncbi.nlm.nih.gov/pubmed/34514306", "https://www.ncbi.nlm.nih.gov/pubmed/34955479", "https://www.ncbi.nlm.nih.gov/pubmed/33444297", "https://www.ncbi.nlm.nih.gov/pubmed/34192428", "https://www.ncbi.nlm.nih.gov/pubmed/34866957", "https://www.ncbi.nlm.nih.gov/pubmed/34865500", "https://www.ncbi.nlm.nih.gov/pubmed/34311983", "https://www.ncbi.nlm.nih.gov/pubmed/34904134", "https://www.ncbi.nlm.nih.gov/pubmed/34277198", "https://www.ncbi.nlm.nih.gov/pubmed/34731877", "https://www.ncbi.nlm.nih.gov/pubmed/34533570", "https://www.ncbi.nlm.nih.gov/pubmed/34229940", "https://www.ncbi.nlm.nih.gov/pubmed/34336774", "https://www.ncbi.nlm.nih.gov/pubmed/34006408", "https://www.ncbi.nlm.nih.gov/pubmed/34614329", "https://www.ncbi.nlm.nih.gov/pubmed/33262177", "https://www.bitchute.com/video/uT8ErRzTsy9V/", "https://cienciaysaludnatural.com/estudio-demuestra-mucho-riesgo-y-ningun-beneficio-inyectar-a-menores-contra-k0-b1t/", "http://www.facebook.com/sharer.php?u=https://cienciaysaludnatural.com/?p=13233", "https://twitter.com/intent/tweet?text=140+estudios+cient%C3%ADficos+sobre+eventos+adversos+de+la+inyecci%C3%B3n+K0+B1T+que+pueden+ocurrir+en+los+ni%C3%B1os&url=https://cienciaysaludnatural.com/?p=13233", "https://cienciaysaludnatural.com/para-firmar-notificacion-al-pueblo-de-la-nacion-argentina-y-a-los-responsables-de-la-politica-sanitaria/", "https://cienciaysaludnatural.com/860-estudios-sobre-efectos-adversos-y-muertes-asociados-a-la-inyeccion-k0-b1t/", "https://cienciaysaludnatural.com/fda-quiere-ocultar-documentos-por-75-anos-porque-serian-incriminados/", "https://cienciaysaludnatural.com/vacuna-antigripal-nasal-infantil-peligro-inminente/", "https://cienciaysaludnatural.com/vacuna-antigripal-nasal-infantil-peligro-inminente/", "https://cienciaysaludnatural.com/las-tasas-de-mortalidad-materna-aumentan-e-ignoran-la-vacunacion-k0-b1t-como-causa/", "https://cienciaysaludnatural.com/las-tasas-de-mortalidad-materna-aumentan-e-ignoran-la-vacunacion-k0-b1t-como-causa/", "https://cienciaysaludnatural.com/mayor-probabilidad-de-enfermedades-cronicas-en-menores-vacunados-que-en-no-vacunados/", "https://cienciaysaludnatural.com/mayor-probabilidad-de-enfermedades-cronicas-en-menores-vacunados-que-en-no-vacunados/", "https://cienciaysaludnatural.com/diente-de-leon-dandelion/", "https://cienciaysaludnatural.com/diente-de-leon-dandelion/", "https://cienciaysaludnatural.com/melisa/", "https://cienciaysaludnatural.com/melisa/", "https://cienciaysaludnatural.com/manzanilla/", "https://cienciaysaludnatural.com/manzanilla/", "https://cienciaysaludnatural.com/pasionaria/", "https://cienciaysaludnatural.com/pasionaria/", "https://cienciaysaludnatural.com/espino-blanco-y-espino-comun/", "https://cienciaysaludnatural.com/espino-blanco-y-espino-comun/", "https://cienciaysaludnatural.com/plantas-medicinales-para-mejorar-la-salud-del-cerebro/", "https://cienciaysaludnatural.com/plantas-medicinales-para-mejorar-la-salud-del-cerebro/", "https://cienciaysaludnatural.com/artemisia-annua/", "https://cienciaysaludnatural.com/artemisia-annua/", "https://cienciaysaludnatural.com/agujas-de-pino-blanco-suramina/", "https://cienciaysaludnatural.com/agujas-de-pino-blanco-suramina/", "https://cienciaysaludnatural.com/ginkgo-biloba/", "https://cienciaysaludnatural.com/ginkgo-biloba/", "https://cienciaysaludnatural.com/tratamiento-para-disolver-la-proteina-spike-toxica-que-produce-la-inyeccion-k0-b1t-con-la-nattoquinasa/", "https://cienciaysaludnatural.com/tratamiento-para-disolver-la-proteina-spike-toxica-que-produce-la-inyeccion-k0-b1t-con-la-nattoquinasa/", "https://cienciaysaludnatural.com/category/5g/", "https://cienciaysaludnatural.com/category/ade/", "https://cienciaysaludnatural.com/category/adn/", "https://cienciaysaludnatural.com/category/agenda-2030/", "https://cienciaysaludnatural.com/category/aluminio/", "https://cienciaysaludnatural.com/category/anticuerpos/", "https://cienciaysaludnatural.com/category/antineumococica/", "https://cienciaysaludnatural.com/category/argentina/", "https://cienciaysaludnatural.com/category/astrazeneca/", "https://cienciaysaludnatural.com/category/atrazina/", "https://cienciaysaludnatural.com/category/autismo/", "https://cienciaysaludnatural.com/category/autoinmunidad/", "https://cienciaysaludnatural.com/category/bcg/", "https://cienciaysaludnatural.com/category/calendario-vac/", "https://cienciaysaludnatural.com/category/cancer/", "https://cienciaysaludnatural.com/category/cardiaco/", "https://cienciaysaludnatural.com/category/cdc/", "https://cienciaysaludnatural.com/category/cds/", "https://cienciaysaludnatural.com/category/censuras/", "https://cienciaysaludnatural.com/category/clima/", "https://cienciaysaludnatural.com/category/calentamiento/", "https://cienciaysaludnatural.com/category/consumismo/", "https://cienciaysaludnatural.com/category/covishield/", "https://cienciaysaludnatural.com/category/cuarentenas/", "https://cienciaysaludnatural.com/category/culebrilla/", "https://cienciaysaludnatural.com/category/cultura/", "https://cienciaysaludnatural.com/category/declaraciones/", "https://cienciaysaludnatural.com/category/delta/", "https://cienciaysaludnatural.com/category/dengue/", "https://cienciaysaludnatural.com/category/dtap/", "https://cienciaysaludnatural.com/category/dtp/", "https://cienciaysaludnatural.com/category/ebola/", "https://cienciaysaludnatural.com/category/ecologia/", "https://cienciaysaludnatural.com/category/educacion/", "https://cienciaysaludnatural.com/category/efectos-adversos/", "https://cienciaysaludnatural.com/category/eficiencia/", "https://cienciaysaludnatural.com/category/embarazadas/", "https://cienciaysaludnatural.com/category/epidemiologos/", "https://cienciaysaludnatural.com/category/estudios/", "https://cienciaysaludnatural.com/category/eventos/", "https://cienciaysaludnatural.com/category/fda/", "https://cienciaysaludnatural.com/category/fertilidad/", "https://cienciaysaludnatural.com/category/fluor/", "https://cienciaysaludnatural.com/category/fracking/", "https://cienciaysaludnatural.com/category/fraude/", "https://cienciaysaludnatural.com/category/glaxo/", "https://cienciaysaludnatural.com/category/glifosato/", "https://cienciaysaludnatural.com/category/globalizacion/", "https://cienciaysaludnatural.com/category/gripe/", "https://cienciaysaludnatural.com/category/guillain-barre/", "https://cienciaysaludnatural.com/category/hepatitis-b/", "https://cienciaysaludnatural.com/category/herpes/", "https://cienciaysaludnatural.com/category/hidroxicloroquina/", "https://cienciaysaludnatural.com/category/hierbas/", "https://cienciaysaludnatural.com/category/ingenieria-social/", "https://cienciaysaludnatural.com/category/inmunidad/", "https://cienciaysaludnatural.com/category/ivermectina/", "https://cienciaysaludnatural.com/category/jj/", "https://cienciaysaludnatural.com/category/legales/", "https://cienciaysaludnatural.com/category/marburg/", "https://cienciaysaludnatural.com/category/mascaras/", "https://cienciaysaludnatural.com/category/meningococo/", "https://cienciaysaludnatural.com/category/menores/", "https://cienciaysaludnatural.com/category/moderna/", "https://cienciaysaludnatural.com/category/muerte-subita/", "https://cienciaysaludnatural.com/category/muertes/", "https://cienciaysaludnatural.com/category/omicron/", "https://cienciaysaludnatural.com/category/oms/", "https://cienciaysaludnatural.com/category/paperas/", "https://cienciaysaludnatural.com/category/pcr/", "https://cienciaysaludnatural.com/category/pesticidas/", "https://cienciaysaludnatural.com/category/peticiones/", "https://cienciaysaludnatural.com/category/pfizer/", "https://cienciaysaludnatural.com/category/plantas-medicinales/", "https://cienciaysaludnatural.com/category/polio/", "https://cienciaysaludnatural.com/category/politica/", "https://cienciaysaludnatural.com/category/prontuarios/", "https://cienciaysaludnatural.com/category/prospectos/", "https://cienciaysaludnatural.com/category/recientes/", "https://cienciaysaludnatural.com/category/remdesivir/", "https://cienciaysaludnatural.com/category/reportar/", "https://cienciaysaludnatural.com/category/salud/", "https://cienciaysaludnatural.com/category/sarampion/", "https://cienciaysaludnatural.com/category/seguridad/", "https://cienciaysaludnatural.com/category/sida-vih/", "https://cienciaysaludnatural.com/category/sin-categoria/", "https://cienciaysaludnatural.com/category/sinopharm/", "https://cienciaysaludnatural.com/category/sociedad/", "https://cienciaysaludnatural.com/category/spike/", "https://cienciaysaludnatural.com/category/sputnik/", "https://cienciaysaludnatural.com/category/tapabocas/", "https://cienciaysaludnatural.com/category/tecnologia/", "https://cienciaysaludnatural.com/category/tendencias/", "https://cienciaysaludnatural.com/category/testimonios/", "https://cienciaysaludnatural.com/category/tests/", "https://cienciaysaludnatural.com/category/tetanos/", "https://cienciaysaludnatural.com/category/transfeccion/", "https://cienciaysaludnatural.com/category/transgenero/", "https://cienciaysaludnatural.com/category/transgenicos/", "https://cienciaysaludnatural.com/category/transhumanismo/", "https://cienciaysaludnatural.com/category/trata-de-personas/", "https://cienciaysaludnatural.com/category/tratamientos/", "https://cienciaysaludnatural.com/category/vacunas/", "https://cienciaysaludnatural.com/category/varicela/", "https://cienciaysaludnatural.com/category/vaxelis/", "https://cienciaysaludnatural.com/category/video/", "https://cienciaysaludnatural.com/category/viruela/", "https://cienciaysaludnatural.com/category/vitamina-k/", "https://cienciaysaludnatural.com/category/vph-papiloma/", "https://cienciaysaludnatural.com/category/wuhan/", "https://cienciaysaludnatural.com", "https://cienciaysaludnatural.com/feed/", "https://www.facebook.com/cienciaysaludnaturalcom", "https://twitter.com/cienciaysaludn1"]}